Trajectory of response to esketamine nasal spray for treatment resistant depression: Findings from ESCAPE-TRD. | ClinicLens
Previous research has demonstrated the positive impact of early remission on disease trajectory for patients with major depressive disorder. However, there is a paucity of literature assessing the response trajectory for patients with treatment resistant depression (TRD). These a
Medical Literature · Updated
← Back to articlesIf the embedded page does not load in your browser, open it directly.